芯片上器官
药物开发
药物发现
药品
制药工业
计算机科学
医学
风险分析(工程)
生物信息学
药理学
纳米技术
生物
材料科学
微流控
作者
Yanping Wang,Yanfeng Gao,Yongchun Pan,Dongtao Zhou,Yuta Liu,Yi Yin,Jingjing Yang,Yuzhen Wang,Yujun Song
标识
DOI:10.1016/j.apsb.2023.02.006
摘要
New drug discovery is under growing pressure to satisfy the demand from a wide range of domains, especially from the pharmaceutical industry and healthcare services. Assessment of drug efficacy and safety prior to human clinical trials is a crucial part of drug development, which deserves greater emphasis to reduce the cost and time in drug discovery. Recent advances in microfabrication and tissue engineering have given rise to organ-on-a-chip, an in vitro model capable of recapitulating human organ functions in vivo and providing insight into disease pathophysiology, which offers a potential alternative to animal models for more efficient pre-clinical screening of drug candidates. In this review, we first give a snapshot of general considerations for organ-on-a-chip device design. Then, we comprehensively review the recent advances in organ-on-a-chip for drug screening. Finally, we summarize some key challenges of the progress in this field and discuss future prospects of organ-on-a-chip development. Overall, this review highlights the new avenue that organ-on-a-chip opens for drug development, therapeutic innovation, and precision medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI